The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway
Top Cited Papers
- 2 May 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (18) , 7100-7105
- https://doi.org/10.1073/pnas.0602184103
Abstract
The NS1 protein of influenza A virus (NS1A protein) is a multifunctional protein that counters cellular antiviral activities and is a virulence factor. Its N-terminal RNA-binding domain binds dsRNA. The only amino acid absolutely required for dsRNA binding is the R at position 38. To identify the role of this dsRNA-binding activity during influenza A virus infection, we generated a recombinant influenza A/Udorn/72 virus expressing an NS1A protein containing an RNA-binding domain in which R38 is mutated to A. This R38A mutant virus is highly attenuated, and the mutant NS1A protein, like the WT protein, is localized in the nucleus. Using the R38A mutant virus, we establish that dsRNA binding by the NS1A protein does not inhibit production of IFN-beta mRNA. Rather, we demonstrate that the primary role of this dsRNA-binding activity is to protect the virus against the antiviral state induced by IFN-beta. Pretreatment of A549 cells with IFN-beta for 6 h did not inhibit replication of WT Udorn virus, whereas replication of R38A mutant virus was inhibited 1,000-fold. Using both RNA interference in A549 cells and mouse knockout cells, we show that this enhanced sensitivity to IFN-beta-induced antiviral activity is due predominantly to the activation of RNase L. Because activation of RNase L is totally dependent on dsRNA activation of 2'-5' oligo (A) synthetase (OAS), it is likely that the primary role of dsRNA binding by the NS1A protein in virus-infected cells is to sequester dsRNA away from 2'-5' OAS.Keywords
This publication has 39 references indexed in Scilit:
- The CPSF30 Binding Site on the NS1A Protein of Influenza A Virus Is a Potential Antiviral TargetJournal of Virology, 2006
- Biophysical Characterization of the Complex between Double-Stranded RNA and the N-Terminal Domain of the NS1 Protein from Influenza A Virus: Evidence for a Novel RNA-Binding ModeBiochemistry, 2004
- Crystal Structure of the 2′-Specific and Double-Stranded RNA-Activated Interferon-Induced Antiviral Protein 2′-5′-Oligoadenylate SynthetaseMolecular Cell, 2003
- Effects of Influenza A Virus NS1 Protein on Protein Expression: the NS1 Protein Enhances Translation and Is Not Required for Shutoff of Host Protein SynthesisJournal of Virology, 2002
- Functional Characterization of and Cooperation between the Double-stranded RNA-binding Motifs of the Protein Kinase PKRJournal of Biological Chemistry, 2001
- Inhibition of Interferon-Mediated Antiviral Responses by Influenza A Viruses and Other Negative-Strand RNA VirusesVirology, 2001
- Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta InterferonJournal of Virology, 2000
- Novel functions of interferon-induced proteinsSeminars in Cancer Biology, 2000
- Distribution of Immunoreactive 2′,5′Oligoadenylate Synthetase in Mouse Digestive TractJournal of Interferon & Cytokine Research, 1995
- Binding of influenza A virus NS1 protein to dsRNA in vitroJournal of General Virology, 1992